- Trials with a EudraCT protocol (36)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
36 result(s) found for: Neostigmine.
Displaying page 1 of 2.
| EudraCT Number: 2014-002021-35 | Sponsor Protocol Number: ANR-1/14 | Start Date*: 2014-09-23 |
| Sponsor Name:Fondazione IRCCS Istituto Nazionale dei Tumori | ||
| Full Title: Decurarization After Thoracic Anesthesia - A prospective multicenter double-blind randomized trial comparing sugammadex vs neostigmine reversal after thoracic anesthesia | ||
| Medical condition: Neuromuscular block is commonly adopted during general anesthesia to facilitate tracheal intubation, mechanical ventilation and surgical manipulation. At the end of anesthesia it very important to ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-002528-10 | Sponsor Protocol Number: SIVAA01 | Start Date*: 2017-07-06 |
| Sponsor Name:Vestfold Hospital Trust | ||
| Full Title: TOF trial: A randomized double blinded controlled Trial comparing low dose Of sugammadex and neostigmine aFter use of rocuronium during general anesthesia in patients undergoing non-cardiac surgery | ||
| Medical condition: The study population will include all patients >18 years scheduled for an elective surgical procedure undergoing general anesthesia with intravenous drugs and non-depolarizing NMBA (rocuronium), wi... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002187-26 | Sponsor Protocol Number: neostigmine2019 | Start Date*: 2019-08-28 |
| Sponsor Name:KU Leuven - TARGID | ||
| Full Title: A Prospective evaluation of the effect of a single dose of neostigmine in patients with patients with weak or absent esophageal peristalsis | ||
| Medical condition: Patients with complaints of dysphagia and poor esophageal motility | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-005512-12 | Sponsor Protocol Number: MVDV | Start Date*: 2007-12-19 |
| Sponsor Name:University Hospitals Leuven | ||
| Full Title: Een verbetering van de analgesie na episiotomie door epidurale toediening van neostigmine en clonidine. | ||
| Medical condition: Combinedn spinal-epidural analgesia during labour. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-000561-20 | Sponsor Protocol Number: 020186 | Start Date*: 2020-02-28 |
| Sponsor Name:Tampere University Hospital | ||
| Full Title: Monitoring of neuromuscular blockade during general anaesthesia after reversal with neostigmine | ||
| Medical condition: We are studying reappearence of nondepolarizing neuromuscular block after it has been antagonized with a combination of neostigmine and glycopyrrolate. We are trying to find the incidence of the ph... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-002078-30 | Sponsor Protocol Number: REDNES06052013 | Start Date*: 2013-08-08 |
| Sponsor Name:Onze-Lieve-Vrouw Ziekenhuis | ||
| Full Title: Acceleromyography and diaphragm electromyographic activity during neostigmine or sugammadex enhanced recovery from moderate residual neuromuscular blockade after rocuronium 0.6 mg kg-1: a double bl... | ||
| Medical condition: We will compare usual care (neostigmine) with sugammadex for reversal of a moderate rocuronium-induced neuromuscular blockade and assess the effect on diaphragmatic EMG activity of sugammadex versu... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001135-30 | Sponsor Protocol Number: 19.4.301 | Start Date*: 2005-10-18 |
| Sponsor Name:NV Organon | ||
| Full Title: A multi-center, randomized, parallel group, comparative, active controlled, safety-assessor blinded, phase IIIa, pivotal trial, in adult subjects comparing Org 25969 with neostigmine as reversal ag... | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) SE (Completed) GB (Completed) ES (Completed) IT (Completed) BE (Completed) DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-005116-41 | Sponsor Protocol Number: AOP0071 | Start Date*: 2015-06-24 |
| Sponsor Name:University of Padova | ||
| Full Title: Postoperative pulmonary function in patients undergoing laparoscopic sleeve gastrectomy after administration of sugammadex and neostigmine. A double-blind, randomized controlled trial. | ||
| Medical condition: Reversal of rocuronium-induced neuromuscular blockade | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: IT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-005845-12 | Sponsor Protocol Number: 11/2006 - MVdV | Start Date*: 2007-01-08 |
| Sponsor Name:UZ leuven, Marc Van de Velde | ||
| Full Title: Combined spinal-epidural anaesthesia during labour : has the epidural administration of clonidine and neostigmine a positive influence on the quality of analgesia ? | ||
| Medical condition: combined spinal-epidural analgesia during labour | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-008434-36 | Sponsor Protocol Number: VDV12/08 | Start Date*: 2009-02-12 |
| Sponsor Name:Marc Van de Velde | ||
| Full Title: Een gecombineerde spinale epidurale anesthesie bij arbeid : positieve invloed op kwaliteit van analgesie door epiduraal clonidine en neostigmine bij doorbraakpijn? | ||
| Medical condition: Combined spinal-epidural analgesia during labour | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-008239-27 | Sponsor Protocol Number: SUNDRO | Start Date*: 2009-02-13 | ||||||||||||||||
| Sponsor Name:Technische Universität München | ||||||||||||||||||
| Full Title: Dosisfindungsstudie Sugammadex und Neostigmin bei geringer neuromuskulärer Restblockade (Sugammadex and Neostigmine dose finding study for reversal of residual neuromuscular blockade) | ||||||||||||||||||
| Medical condition: Dose finding study for sugammadex and/or neostigmine at residual neuromuscular blockade (whereas residual neuromuscular blockade is defined as a TOF of 0.5 in this study). | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2009-013499-29 | Sponsor Protocol Number: SUNDRO20 | Start Date*: Information not available in EudraCT | ||||||||||||||||
| Sponsor Name:Technische Universität München | ||||||||||||||||||
| Full Title: Dosisfindungsstudie für Sugammadex und Neostigmin zur Reversierung einer geringen neuromuskulären Restblockade (train of four ratio 0,2) [Sugammadex and Neostigmine dose finding study for reversal ... | ||||||||||||||||||
| Medical condition: Dose finding study for sugammadex and/or neostigmine at residual neuromuscular blockade (whereas residual neuromuscular blockade is defined as a TOF of 0.2 in this study). | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2005-001792-35 | Sponsor Protocol Number: 19.4.310 | Start Date*: 2005-09-28 |
| Sponsor Name:NV Organon | ||
| Full Title: Comparison of rocuronium and Org 25969 with cis-atracurium and neostigmine when neuromuscular block is reversed at reappearance of T2 | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-005156-26 | Sponsor Protocol Number: PRIN-SUGAR-2014 | Start Date*: 2015-05-27 |
| Sponsor Name:Dr. Enrique Alday | ||
| Full Title: Effects of neuromuscular block reversal with sugammadex vs neostigmine on postoperative respiratory outcomes after major abdominal surgery. A randomized controlled trial. | ||
| Medical condition: Patients of both sexes proposed for major abdominal surgery under general anesthesia plus epidural | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-007951-14 | Sponsor Protocol Number: 19.4.318 | Start Date*: 2008-05-05 |
| Sponsor Name:NV Organon | ||
| Full Title: A multi-center, randomized, parallel-group, comparative, active-controlled, safety-assessor blinded trial in adult subjects comparing the efficacy and safety of sugammadex administered at 1-2 PTC w... | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) GB (Completed) DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-006304-37 | Sponsor Protocol Number: 19.4.324 | Start Date*: 2008-03-19 |
| Sponsor Name:NV Organon | ||
| Full Title: A multi-center, randomized, parallel-group, active-controlled, safety-assessor blinded trial, comparing the efficacy and safety of 2.0 mg.kg-1 sugammadex with 50 μg.kg-1 neostigmine administered at... | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Completed) BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-000401-50 | Sponsor Protocol Number: CT-PED-2010-01 | Start Date*: 2011-08-09 | |||||||||||
| Sponsor Name:Fundación para la Formación e Investigación Sanitarias de la Región de Murcia | |||||||||||||
| Full Title: Efficacy and safety of reversal with Sugammadex (BRIDION®) from deep Neuromuscular Blockade induced by rocuronium in children | |||||||||||||
| Medical condition: Neuromuscular Blockade induced by Rocuronium | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-004666-34 | Sponsor Protocol Number: AITT2014/1 | Start Date*: 2014-03-17 |
| Sponsor Name:University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy | ||
| Full Title: Reversal of vecuronium induced residual neuromuscular block using sugammadex: a prospective, dobule-blind, randomized, controlled, dosefinding study | ||
| Medical condition: The effect of sugammadex dose on residual neuromuscular blockade will be investigated, therefore patients suffering from various conditions undergoing surgery in general anaesthesia with muscle rel... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005222-19 | Sponsor Protocol Number: BREATH | Start Date*: 2016-07-14 | |||||||||||
| Sponsor Name:Leiden University Medical Center | |||||||||||||
| Full Title: Effect of neuromuscular blockade and reversal by sugammadex versus neostigmine on breathing when hypoxic or hypercapnic in volunteers | |||||||||||||
| Medical condition: Postoperative ventilatory control | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-000692-92 | Sponsor Protocol Number: MK-8616-089 | Start Date*: 2019-02-01 | |||||||||||
| Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
| Full Title: A Phase 4 Double-Blinded, Randomized, Active Comparator-Controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade ... | |||||||||||||
| Medical condition: Reversal of neuromuscular blockade (NMB) | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) ES (Completed) FI (Completed) BE (Completed) DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
